DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Greene LA, Thalji NK, Raffini LJ, Camire RM.
Abstract: Zymogen-like FXa variant as a short-acting warfarin reversal agent: pre-clinical evaluation and mechanism of action.
Blood 2014;124(4262):
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.